Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide
- 1 December 1984
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 27 (6) , 604-606
- https://doi.org/10.1007/bf00276978
Abstract
Cyclophosphamide promoted the onset of overt diabetes in non-obese diabetes-prone mice of both sexes. Two injections of this agent at 2 weeks apart were necessary to obtain a constant high incidence, although even a single injection was effective in some animals. Clinical symptoms of the cyclophosphamide-induced diabetes were similar to those of the naturally occurring type. The same schedule of cyclophosphamide treatment failed to induce diabetes in non-diabetic mouse strains, such as DS/Shi, Jcl: ICR or in non-obese non-diabetes-prone mice, which suggests that the promotion of diabetes by cyclophosphamide in non-obese diabetes-prone mice is not due to the simple pharmacological action of this agent but to some immunopharmacological action.Keywords
This publication has 19 references indexed in Scilit:
- Multiple organ-reactive monoclonal autoantibodiesNature, 1983
- Spontaneous Autoimmune Diabetes Mellitus in the BB RatDiabetes, 1982
- Induction of experimental autoimmune diabetes by low-dose streptozotocin treatment in genetically resistant miceImmunology Letters, 1981
- Induction of experimental allergic encephalomyelitis in genetically resistant strains of miceNature, 1980
- Islet-Cell-Surface Antibodies in Juvenile Diabetes MellitusNew England Journal of Medicine, 1978
- The spontaneously diabetic Wistar rat (the ?BB? rat)Diabetologia, 1978
- Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in miceNature, 1976
- Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.The Journal of Experimental Medicine, 1975
- ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIESThe Lancet, 1974
- POTENTIATION OF T-CELL-MEDIATED IMMUNITY BY SELECTIVE SUPPRESSION OF ANTIBODY FORMATION WITH CYCLOPHOSPHAMIDEThe Journal of Experimental Medicine, 1974